Donate

Our Impact

Every gift to Vs. Cancer does two jobs: make life better for kids currently fighting cancer and fund research into life-saving treatments for childhood cancer.

Vs. Cancer ensures that of every dollar raised, one half goes to a local childhood cancer hospital in your community, and one half funds groundbreaking pediatric brain tumor research.

Local Hospital Programs Funded

2016
Brenner's Children's Hospital

Vs. Cancer’s support will help Brenner’s build a much more expansive playroom space for the pediatric hem/onc patients. The desire is that the space will have a component targeted for teens as well.

Local Hospital Programs Funded

2016
Seattle Children’s Hospital

With funding from Vs. Cancer, Seattle Children’s Child Life Department will be able to update the gaming systems available for kids to check out, plus refresh a space on the unit that will be dedicated as a “Teen Zone” and, as such, will need a game system to be part of the equation.

Local Hospital Programs Funded

2016
Children’s Hospital of Greenville Health System

With Vs. Cancer’s support, GHS Children’s will expand its existing Pediatric Survivorship Clinic to help patients and their families navigate life beyond cancer. In order to translate the vision of creating a future forward survivorship program that keeps quality care close to home, philanthropic support is utilized with a Pediatric Nurse Practitioner who is the key to the success of expanding the survivorship program responsible for creating new programs as well as strengthening existing ones and education and outreach to raise the visibility of the cancer survivorship program.

Local Hospital Programs Funded

2016
The Children’s Hospital of Philadelphia

Funds supported Child Life Oncology’s Teen Outpatient Programing. Specifically, for AYA targeted events/activities during Childhood Cancer Awareness Month in September and Teen Cancer Awareness Week in January. Additionally, funds will be used for the continuation of the Wednesday Society AYA Social Group.

Local Hospital Programs Funded

2016
Dana-Farber Cancer Institute

Vs. Cancer is supporting Dana-Farber’s School Liason Program’s unique focus on survivorship, and its approach to providing services in a school-based setting, means funding is not often readily available. As a result, the SLP’s important work is solely covered by philanthropic means, and  continue to have an ongoing need for funding.

Local Hospital Programs Funded

2016
Children’s Hospital of Pittsburgh

Vs. Cancer is supporting the Adolescent and Young Adult (AYA) Oncology Program at Children’s Hospital of Pittsburgh of UPMC (CHP). In cooperation with our adult oncology colleagues at the University of Pittsburgh Cancer Institute (UPCI), AYA serves adolescents and young adults who are being treated for cancer at our hospital. This program was established to provide the best multidisciplinary care for patients aged 15-22, a traditionally underserved population at pediatric hospitals in terms of age-appropriate programming and activities. In addition to cutting edge oncology care, we offer psychosocial support, fertility counseling, and peer support groups—in the form of weekend getaways and parties—and are therefore able to provide focused attention to the unique social, emotional, and physical needs of adolescents and young adults.

“We are so thankful to the Texas A&M Baseball Team for raising funds and awareness for cancer research in such an interactive way. Their gift of a portable therapy machine will have a significant impact on our patients’ lives at the MD Anderson Children’s Cancer Hospital. We thank everyone involved for your support in Making Cancer History.”

-Ron DePinho, M.D., President of MD Anderson Cancer Center

Research Funded

2015
Pediatric Neuro-Oncology Consortium, Collaboration with the Pediatric Brain Tumor Foundation

PNOC is a network of 11 children’s hospitals that conduct clinical trials of new therapies for children with brain tumors. Patients with brain tumors that cannot be treated with standard therapy, or that have recurred following standard therapy, are often eligible for clinical trials. Clinical trials provide access to promising new treatments that may not be available outside specialized centers. PNOC focuses on personalized medicine – testing new therapies that are specific to the biology of each patient’s tumor to maximize their effectiveness. Our funding will help the network collaborate productively.

2015
Sarcoma Immunotherapies, MD Anderson Cancer Center

Doctors within MD Anderson’s Children’s Cancer Hospital have embarked on a unified effort to improve treatment options for pediatric patients with osteosarcoma (bone) and rhabdomyosarcoma (muscle groups). The five-year survival rate has stagnated over the last 25 years — somewhere between 65-70 percent. Once the cancer metastasizes to the lungs, that number drops to 30 percent.  We are now looking to test the effectiveness of NK cells as they interact with other immuno-building blocks.

With the immediate goal of improving survival rates for pediatric osteosarcoma and rhabdomyosarcoma, and eventually applying that knowledge to establish a cure against all sarcomas, our team of pediatric oncologists and basic science collaborators is poised for Making Cancer History.

2015
International Germinoma Tumor Collaboration, Children’s Healthcare of Atlanta/Aflac Cancer Center, 
2013-2015
Jim Olson Fred Hutchinson Cancer Research Center
Research:

Project Violet: Tumor Paint BLZ-100, initiate a trial in pediatric patients

2014
Jason Yustein, Baylor College of Medicine
Research:

Dissecting and Targeting the WNT Pathway in Metastatic Osteosarcoma

2014
Vidya Gopalakrishnan, University of Texas M.D. Anderson Cancer Center
Research:

Pre-clinical and Clinical Investigations of REST in Medulloblastoma

2014
Jacqueline Kraveka, Medical University of South Carolina
Research:

Targeting Dihydroceramide Desaturase in Neuroblastoma

2014
Dai Chung, Vanderbilt University Medical Center
Research:

Nanotube-mediated siRNA delivery system in the treatment of neuroblastoma

2013
Ian Davis, Lineberger Comprehensive Cancer Center
Research:

For Ewing sarcoma, a pediatric and young adult bone and soft tissue tumor, we have shown that the key genetic change in the tumor cell changes the way that DNA is organized in the cell nucleus in a fundamental way. We are now beginning to understand what these alterations do and through this we hope to develop novel therapeutics to target these processes.

2015
Pediatric Brain Tumor Tissue Consortium, Children’s Hospital of Philadelphia
2015
Dr. Paul Northcott, St. Jude Children's Research Hospital, Pediatric Research Fellow in conjunction with the V Foundation
Research:

Solving the molecular and cellular basis of medulloblastoma, the most common and among the most aggressive types of malignant brain cancer in children. As a PhD student and postdoctoral fellow, Dr. Northcott invested more than 10 years investigating the genetics and epigenetics responsible for medulloblastoma development, identifying biologically and clinically relevant insights into how this deadly pediatric brain tumor develops and why some patients respond very well to current treatments whereas others unfortunately have a dismal outcome. Now in his own lab at St. Jude, he is taking these discoveries to the next level and using state-of-the-art approaches to better understand how specific gene mutations cause medulloblastoma and determine whether these mutations can be exploited to more effectively treat the disease. These studies are a vital next-step towards a cure as we transition from an era of discovering and cataloguing mutated genes to one of functional validation and development of novel, molecularly targeted therapies.

2014
Simone Sredni, Ann & Robert H. Lurie Children’s Hospital of Chicago
Research:

Investigating New Therapeutic Targets for Malignant Rhabdoid Tumors

2014
Jamie Anastas, Children’s Hospital Boston
Research:

The role of ATRX and H3.3 mutations in pediatric glioblastoma

2014
Marta Sanchez Martin (Fellow), Columbia University Medical Center
Research:

New Synergistic drug combinations for the treatment of T-ALL

2014
Courtney Crane, Seattle Children’s Hospital
Research:

Effects of pediatric brain tumors on Natural Killer cell function

2013-2014
Gregory Friedman, Children’s Hospital of Alabama
Research:

Targeting Pediatric Medulloblastoma with Engineered Herpes Simplex Virus

2013
Alex Huang, Rainbow Babies & Children’s Hospital
Research:

How best to use the body’s own immune system to fight aggressive and metastatic cancers including osteosarcoma, T-cell acute lymphoblastic leukemia, medulloblastoma and other CNS tumor

Across the globe and in our backyards, we are promising kids that everybody is Vs. Cancer.

See previous years impact documents: 2014 | 2013

Download our 2014-15 Annual Report